Prebuilt Receptor Library Speeds Personalized T-Cell Therapy.

A prebuilt library of T-cell receptors against recurring TP53 mutations enabled personalized autologous T-cell therapy, producing responses lasting 6 to 19 months in early clinical testing.

• Why it matters: The work addresses the long turnaround of bespoke receptor hunting, aiming to speed personalized T-cell therapy development for patients with recurring TP53 mutations.
• What they did: Clinicians used ready-made T-cell receptor candidates targeting recurring TP53 mutations to generate an autologous therapy, avoiding months of custom receptor selection.
• The result: Early clinical testing showed patient responses persisted for 6 to 19 months, suggesting this approach can shorten personalization timelines while maintaining durable activity.

AI summary of the abstract · may contain errors · not medical advice · read the paper.